A total of 202 methicillin-resistant Staphylococcus aureus (MRSA) single-patient isolates recovered between January and June 1998 in two hospitals in Miami, Florida, were characterized by a combination of several molecular typing techniques: multilocus sequence typing, spaA typing, pulsed-field gel electrophoresis, and determination of the structure of the SCCmec element. The overwhelming majority of the isolates-187of 202, or 93%-belonged to one of three internationally spread epidemic clones which were identified on the basis of their multilocus sequence type (ST) as E-MRSA-16 (ST36), the New York clone V (ST8), and the New York/Japan clone (ST5; SCCmec II) and its single-and double-locus variants. The rest of the isolates (15 of 202, or 7%) were more genetically diverse and were each recovered from a few patients only. Of the 23 MRSA strains isolated from confirmed human immunodeficiency virus-positive patients, as many as 17 (or 70%) belonged to a single ST8 clone carrying SCCmec type IV. The data provide further evidence for the conclusion of earlier studies that most MRSA disease in hospitals is caused by relatively few pandemic clones.
The introduction of molecular typing techniques into epidemiological investigations has provided powerful new tools for tracking the origin and routes of dissemination of methicillinresistant Staphylococcus aureus (MRSA) strains not only among patients in a hospital but also among hospitals in different countries or even across different continents. One of the interesting conclusions that have emerged from large international surveillance studies using such molecular typing techniques is that a relatively few MRSA clones have been responsible for a disproportionately large fraction of all MRSA disease worldwide (8, 16) . In addition these studies have also indicated a considerable degree of geographic specificity in the spread of various MRSA lineages. For instance, the Iberian clone of MRSA was found to be the dominant clone in hospitals in Southern Europe (16) , while the clone referred to as E-MRSA-16 was most frequently recovered in hospitals in the United Kingdom (11) , Canada (24) , and Mexico (2) . In surveillance of MRSA disease in 12 New York City hospitals in 1996 (18) , as many as 42% of all MRSA isolates belonged to the New York/Japan clone. In a follow-up study conducted at 29 hospitals and/or health centers in the tristate area of New Jersey, Pennsylvania, and Connecticut in 1998 (19) , the same clonal type was represented in 92% of the MRSA isolates from the participating centers in Pennsylvania, 65% of MRSA isolates from New Jersey, and 39% of MRSA isolates from Connecticut. The purpose of the study described here was to sample hospitals in the United States at a geographic site distant from the Northeast. Two hospitals, both located in Miami, Florida, were selected for such a study, and the basic observations are described in this communication.
MATERIALS AND METHODS
The first of the two sites selected for the study was The Jackson Memorial Hospital (hospital C), a 1,550-bed hospital that serves the population of MiamiDade County. Services include general acute care, a trauma center, and multiorgan transplantation programs. The second site was the Miami Veterans Affairs Medical Center (hospital D), a 220-bed acute care facility serving the veterans of southeastern Florida. Both hospitals are closely affiliated with the University of Miami School of Medicine. During the calendar year of 1998, the frequency of methicillin resistance among S. aureus isolates was 38% in hospital C and about 50% in hospital D.
Of the MRSA isolates recovered in these two hospitals between 1 June and 23 December 1998, a total of 202 isolates were available for molecular typing: 113 from hospital C and 89 from hospital D. Information was obtained on the source of each isolates (blood, the respiratory tract, wounds, urine, or other [including the nose, stool, and skin]), whether the isolate was collected within the first 72 h of hospitalization (community acquired) or after 72 h of hospitalization (nosocomial), and whether the isolate was from a patient with human immunodeficiency virus infection (if that information was available). The major clinical sources of the MRSA isolates were blood (n ϭ 32), the respiratory tract (n ϭ 53), wounds (n ϭ 25), urine (n ϭ 35), and other sources (n ϭ 57). The great majority of isolates were of nosocomial origin. Species identification and antibiograms were performed at the clinical microbiology laboratories of the hospitals. Cultures were frozen in tryptic soy broth containing 10% glycerol (Difco, Detroit, Mich.) and were stored at Ϫ70°C until transfer to the Laboratory of Microbiology at The Rockefeller University, New York, N.Y., for molecular typing. Table 1 lists the MRSA isolates according to their molecular types and antibiotypes. Multilocus sequence typing (MLST) (6, 7), determination of the spaA type (15, 22) , and pulsed-field gel electrophoresis (PFGE) of SmaI-digested chromosomal DNA (5) were performed by published methods. A multiplex PCR technique was used to identify the type of the mec element (SCCmec type) carried by the bacterium (17) .
RESULTS AND DISCUSSION
We chose a combination of several molecular typing techniques for characterization of the MRSA isolates recovered in the two Miami hospitals, since these methods can complement one another both in terms of expedience and in terms of the type of information they provide. While superior in resolving power, PFGE may blur evolutionary relationships among strains which may be revealed by MLST, particularly when the structure of the SCCmec type is also determined. Experience with the relatively simple sequence-based spaA typing technique, recently introduced, indicates that this method can frequently predict the MLST type (14, 16) . While short-term epidemiological investigations need high-resolution tracking techniques such as PFGE, additional characterization of strains by MLST and other sequence-based techniques allows one to recognize issues that transcend the geographic boundaries of a hospital and permits insights into the global epide- miology and population biology of S. aureus as well. From this perspective, the molecular typing data generated in the two Miami hospitals allow one to draw several conclusions.
The most frequent MRSA clone in hospital C and the second most frequent clone in hospital D was E-MRSA-16 (ST36) (Fig. 1) . All MRSA isolates belonging to this sequence type in both hospitals were homogeneous: they had identical MLSTs, carried SCCmec type II, and showed a uniform PFGE pattern as well as an invariant spaA type (Fig. 2) . E-MRSA-16 is widespread in the United Kingdom (11) and has also been The second most frequent MRSA clone was the New York clone V (14) , which accounted for 47% of all MRSA isolates in hospital D and was the second most frequent clone (36%) in hospital C (Fig. 1) . This clone was first identified as an epidemic MRSA clone in a surveillance study in New York, N.Y., where it was associated with SCCmec IV and was assigned the multilocus sequence type ST8 (14) . However, the ST8 genetic background was proposed to represent the predicted ancestor of the very first European MRSA strain (8) . Furthermore, a single-locus variant of ST8, MRSA clonal type ST247, also known as the Iberian clone (6) , is one of the most widely spread MRSA clones in Southern and Western Europe (16) . In the two Miami hospitals, most of the strains belonging to ST8 (68 of 73) carried SCCmec type IV but 5 strains of this sequence type were associated with SCCmec type I, which was shown to be present in the first MRSA isolates from the United Kingdom and Denmark (6, 8) . Variation in the SCCmec types associated with this genetic background has been demonstrated previously (8) .
MRSA strains belonging to the New York clone V and carrying SCCmec type IV were recovered with relatively high frequency (70%) from human immunodeficiency virus-positive patients in the two Miami hospitals, and a similar association was noted in a surveillance study in New York (18, 19) . The significance of these observations is not clear at present. Unlike that of SCCmec type I, the structure of SCCmec type IV lacks the pls gene, which may be involved in colonization by S. aureus (16) .
In contrast to the MRSA isolates belonging to the E-MRSA-16 clone, MRSA isolates belonging to the New York clone V showed variations in spaA type (Fig. 2) .
The third most frequent MRSA clone in both Miami hospitals was the New York/Japan clone (multilocus sequence type ST5), together with its single-locus variants ST105 and ST83 and its double-locus variant ST231 (Fig. 1 ). All these strains carried SCCmec type II. MRSA isolates belonging to this clone are most frequent in the northeastern United States (7, 18, 19) , Canada (24) , and Japan (1). All MRSA isolates identified so far in the United States and Japan with reduced susceptibility to vancomycin (so-called VISA strains) belong to this clone (8, 23) . Variations both in spaA type and in PFGE pattern were detected among representatives of this clone (Fig. 2) .
The capacity of each of these three major MRSA clonal types to cause staphylococcal disease is documented by their frequent recovery from all major clinical sites (Fig. 3) .
In contrast to the majority of MRSA isolates represented by the three dominant clones, the rest of the isolates (sporadic MRSA isolates; n ϭ15) were more genetically diverse: they included 9 different sequence types in association with several SCCmec types and 12 distinct PFGE patterns. Three of these genetically diverse isolates were representatives of the Brazilian MRSA clone (ST239 and ST241)-a major internationally spread MRSA lineage (4, 16) . An additional group of five MRSA isolates belonged to ST45-a clone widely spread both as methicillin-susceptible S. aureus (MSSA) and as MRSA in (10) . It is also interesting that three of the genetic backgrounds identified in MRSA isolates from the Miami hospitals, namely, ST9, ST15, and ST97, were reported only as backgrounds of MSSA strains until now. The fact that these genetic backgrounds were identified in MRSA strains in the Miami hospitals is consistent with the notion of the relatively frequent acquisition of the SCCmec element by S. aureus (9, 16) . It is noteworthy that most of these 15 genetically more diverse isolates were associated with hospital C, the patient population of which-in contrast to that of hospital D-is more likely to represent a geographically diverse group (from international patient referrals, immigrants, and tourists visiting the Miami area) that may have been the source of these diverse MRSA isolates. Thus, at least some of the sporadic MRSA isolates identified in hospital C may not have a strictly nosocomial origin. It is interesting in this respect that a few of the sporadic isolates belonging to ST45 had the genetic background also seen in some so-called community-acquired MRSA isolates (13) .
With the continued and increasing mobility of human populations through international travel, it is expected that the geographic boundaries of dominance among MRSA clones will become blurred in time, and the appearance of the genetically diverse sporadic isolates in hospital C may represent this trend. Why such a large proportion of MRSA disease is caused by so few clonal types of bacteria still remains a puzzle, but one component of the extensive geographic spread of these few pandemic MRSA clones may be related to a combination of particular genetic traits in the genetic background of the bacteria (16) .
